Teresa Poggio

8PUBLICATIONS
61CO-AUTHORS
Tumour immunologyHaematological tumoursMolecular targetsSolid tumoursMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 28, 2026
CD4+ T cells orchestrate the immune response to ALK-positive T-cell lymphoma.

|Apr 10, 2024
Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL.

Gaia Gentile, Teresa Poggio, Antonella Catalano

|Dec 14, 2021
Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivo.

Corinna Spohr, Teresa Poggio, Geoffroy Andrieux

|Nov 23, 2019
A novel conditional NPM-ALK-driven model of CD30+ T-cell lymphoma mediated by a translational stop cassette.

Khalid Shoumariyeh, Nicolas Schneider, Teresa Poggio

|Aug 23, 2019
Proteomic Phosphosite Analysis Identified Crucial NPM-ALK-Mediated NIPA Serine and Threonine Residues.

Anina Gengenbacher, Alina Müller-Rudorf, Teresa Poggio

|Jun 13, 2019
NPM1c alters FLT3-D835Y localization and signaling in acute myeloid leukemia.

Alina Rudorf, Tony Andreas Müller, Cathrin Klingeberg

Pageof 2

Frequent Collaborators

3 joint publications

Cornelius Miething

2 joint publications

Tilman Brummer

2 joint publications

Justus Duyster

2 joint publications

Geoffroy Andrieux